PVI
AGN

Pura Vida Investments’s Allergan Inc AGN Stock Holding History

Pura Vida Investments’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-7,000
Closed -$2.32M – 85
2015
Q2 		$2.32M Buy
+7,000
New +$2.32M 1.19% 40
2015
Q1 		– Sell
-21,250
Closed -$4.52M – 104
2014
Q4 		$4.52M Buy
+21,250
New +$4.23M 1.66% 19

Other funds holding AGN

PAA
Peregrine Asset Advisers Portland, Oregon $461M AUM 43.48% 1-Year Est. Return
AWM
Altavista Wealth Management Asheville, North Carolina $496M AUM 20.88% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return
ODCM
Old Dominion Capital Management Charlottesville, Virginia $467M AUM 25.94% 1-Year Est. Return
POA
Pergamon Offshore Advisors New York $91.8M AUM 13.29% 1-Year Est. Return
AAC
Asset Advisors Corp Augusta, Georgia $575M AUM 14.42% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
AGA
Accuvest Global Advisors Provo, Utah $107M AUM 6.41% 1-Year Est. Return
LCM
Liberty Capital Management Birmingham, Michigan $582M AUM

Pura Vida Investments's AGN Position: Q3 2015 in Review

Pura Vida Investments sold out of Allergan Inc (AGN) in Q3 2015, closing a stake of 7,000 shares — an estimated $2.32M sold.

Pura Vida Investments first reported a position in AGN in Q4 2014 and held it in 2 quarters. The position peaked at $4.52M in Q4 2014. 27 funds tracked by Wall St. Rank hold AGN as of Q3 2015.

  • Pura Vida Investments reported no remaining Allergan Inc position as of Q3 2015 after selling out during the quarter.
  • Pura Vida Investments sold 7,000 Allergan Inc shares in Q3 2015, an estimated $2.32M.
  • Pura Vida Investments first reported a position in Allergan Inc in Q4 2014 and held it in 2 quarters.
  • Pura Vida Investments's Allergan Inc position peaked at $4.52M in Q4 2014.
  • 27 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2015.

Based on Pura Vida Investments's 13F filing for Q3 2015, filed 16 Nov 2015.